Hepatitis Viral Disease QSP Model Can Inform Efficacious Dose for Immunotherapy

Speaker(s)

• 

  Meghna Verma, MS, PhD (she/her/hers)

  Associate Director, QSP/T Modeler, Systems Medicine
  AstraZeneca
  Rockville, Maryland, United States